CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial (DLCST): Status after five annual screening rounds with low-dose CT

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial (DLCST) : Status after five annual screening rounds with low-dose CT. / Saghir, Zaigham; Dirksen, Asger; Ashraf, Haseem; Bach, Karen Skjølstrup; Brodersen, John; Clementsen, Paul Frost; Døssing, Martin; Hansen, Hanne; Kofoed, Klaus Fuglsang; Larsen, Klaus Richter; Mortensen, Jann; Rasmussen, Jakob Fraes; Seersholm, Niels; Skov, Birgit Guldhammer; Thorsen, Hanne; Tønnesen, Philip; Pedersen, Jesper Holst.

I: Thorax, Bind 67, Nr. 4, 2012, s. 296-301.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Saghir, Z, Dirksen, A, Ashraf, H, Bach, KS, Brodersen, J, Clementsen, PF, Døssing, M, Hansen, H, Kofoed, KF, Larsen, KR, Mortensen, J, Rasmussen, JF, Seersholm, N, Skov, BG, Thorsen, H, Tønnesen, P & Pedersen, JH 2012, 'CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial (DLCST): Status after five annual screening rounds with low-dose CT', Thorax, bind 67, nr. 4, s. 296-301. https://doi.org/10.1136/thoraxjnl-2011-200736

APA

Saghir, Z., Dirksen, A., Ashraf, H., Bach, K. S., Brodersen, J., Clementsen, P. F., Døssing, M., Hansen, H., Kofoed, K. F., Larsen, K. R., Mortensen, J., Rasmussen, J. F., Seersholm, N., Skov, B. G., Thorsen, H., Tønnesen, P., & Pedersen, J. H. (2012). CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial (DLCST): Status after five annual screening rounds with low-dose CT. Thorax, 67(4), 296-301. https://doi.org/10.1136/thoraxjnl-2011-200736

Vancouver

Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF o.a. CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial (DLCST): Status after five annual screening rounds with low-dose CT. Thorax. 2012;67(4):296-301. https://doi.org/10.1136/thoraxjnl-2011-200736

Author

Saghir, Zaigham ; Dirksen, Asger ; Ashraf, Haseem ; Bach, Karen Skjølstrup ; Brodersen, John ; Clementsen, Paul Frost ; Døssing, Martin ; Hansen, Hanne ; Kofoed, Klaus Fuglsang ; Larsen, Klaus Richter ; Mortensen, Jann ; Rasmussen, Jakob Fraes ; Seersholm, Niels ; Skov, Birgit Guldhammer ; Thorsen, Hanne ; Tønnesen, Philip ; Pedersen, Jesper Holst. / CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial (DLCST) : Status after five annual screening rounds with low-dose CT. I: Thorax. 2012 ; Bind 67, Nr. 4. s. 296-301.

Bibtex

@article{5688bcedd4ef41bba6fc90399dbb0d6c,
title = "CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial (DLCST): Status after five annual screening rounds with low-dose CT",
abstract = "BackgroundThe effects of low-dose CT screening on disease stage shift, mortality and overdiagnosis are unclear. Lung cancer findings and mortality rates are reported at the end of screening in the Danish Lung Cancer Screening Trial.Methods4104 men and women, healthy heavy smokers/former smokers were randomised to five annual low-dose CT screenings or no screening. Two experienced chest radiologists read all CT scans and registered the location, size and morphology of nodules. Nodules between 5 and 15 mm without benign characteristics were rescanned after 3 months. Growing nodules (>25% volume increase and/or volume doubling time15 mm were referred for diagnostic workup. In the control group, lung cancers were diagnosed and treated outside the study by the usual clinical practice.ResultsParticipation rates were high in both groups (screening: 95.5%; control: 93.0%; p",
author = "Zaigham Saghir and Asger Dirksen and Haseem Ashraf and Bach, {Karen Skj{\o}lstrup} and John Brodersen and Clementsen, {Paul Frost} and Martin D{\o}ssing and Hanne Hansen and Kofoed, {Klaus Fuglsang} and Larsen, {Klaus Richter} and Jann Mortensen and Rasmussen, {Jakob Fraes} and Niels Seersholm and Skov, {Birgit Guldhammer} and Hanne Thorsen and Philip T{\o}nnesen and Pedersen, {Jesper Holst}",
year = "2012",
doi = "10.1136/thoraxjnl-2011-200736",
language = "English",
volume = "67",
pages = "296--301",
journal = "Thorax",
issn = "0040-6376",
publisher = "B M J Group",
number = "4",

}

RIS

TY - JOUR

T1 - CT screening for lung cancer brings forward early disease. The Randomised Danish Lung Cancer Screening Trial (DLCST)

T2 - Status after five annual screening rounds with low-dose CT

AU - Saghir, Zaigham

AU - Dirksen, Asger

AU - Ashraf, Haseem

AU - Bach, Karen Skjølstrup

AU - Brodersen, John

AU - Clementsen, Paul Frost

AU - Døssing, Martin

AU - Hansen, Hanne

AU - Kofoed, Klaus Fuglsang

AU - Larsen, Klaus Richter

AU - Mortensen, Jann

AU - Rasmussen, Jakob Fraes

AU - Seersholm, Niels

AU - Skov, Birgit Guldhammer

AU - Thorsen, Hanne

AU - Tønnesen, Philip

AU - Pedersen, Jesper Holst

PY - 2012

Y1 - 2012

N2 - BackgroundThe effects of low-dose CT screening on disease stage shift, mortality and overdiagnosis are unclear. Lung cancer findings and mortality rates are reported at the end of screening in the Danish Lung Cancer Screening Trial.Methods4104 men and women, healthy heavy smokers/former smokers were randomised to five annual low-dose CT screenings or no screening. Two experienced chest radiologists read all CT scans and registered the location, size and morphology of nodules. Nodules between 5 and 15 mm without benign characteristics were rescanned after 3 months. Growing nodules (>25% volume increase and/or volume doubling time15 mm were referred for diagnostic workup. In the control group, lung cancers were diagnosed and treated outside the study by the usual clinical practice.ResultsParticipation rates were high in both groups (screening: 95.5%; control: 93.0%; p

AB - BackgroundThe effects of low-dose CT screening on disease stage shift, mortality and overdiagnosis are unclear. Lung cancer findings and mortality rates are reported at the end of screening in the Danish Lung Cancer Screening Trial.Methods4104 men and women, healthy heavy smokers/former smokers were randomised to five annual low-dose CT screenings or no screening. Two experienced chest radiologists read all CT scans and registered the location, size and morphology of nodules. Nodules between 5 and 15 mm without benign characteristics were rescanned after 3 months. Growing nodules (>25% volume increase and/or volume doubling time15 mm were referred for diagnostic workup. In the control group, lung cancers were diagnosed and treated outside the study by the usual clinical practice.ResultsParticipation rates were high in both groups (screening: 95.5%; control: 93.0%; p

U2 - 10.1136/thoraxjnl-2011-200736

DO - 10.1136/thoraxjnl-2011-200736

M3 - Journal article

C2 - 22286927

VL - 67

SP - 296

EP - 301

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 4

ER -

ID: 34051809